NASDAQ:EDIT (Editas Medicine)
About EDIT
Editas Medicine is a pioneer in gene editing technology. The biotech holds exclusive rights to CRISPR, a mechanism for cutting and pasting changes to DNA at precise locations.
Editas Medicine (NASDAQ: EDIT) Latest News
No posts found.